Summary
This review summarizes experimental studies and clinical experiences with prostaglandins in liver transplantation emphasizing two randomized, double blinded placebo controlled clinical trials of prostaglandin E1 (PGE1) involving nearly 300 liver transplant recipients. Resource utilization and pharmacoeconomic aspects are also discussed. In the randomized trials, PGE1 did not affect patient and graft survival. Acute cellular rejection and primary allograft non-function were not reduced by PGE1. Postoperative renal failure was significantly less frequent among PGE1 patients in both trials and in one study perioperative blood product utilization was significantly lower. PGE1 treated patients had reduced intensive care unit length of stay, shorter hospitalization, and significantly lower total health care charges. Despite its failure to show improvements in patient and graft survival, rejection, or primary non-function, PGE1 use in hepatic allograft recipients reduces morbidity and results in notable reduction in the cost of liver transplantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
United Network for Organ Sharing World Wide Web site. http://www.unos.org
J. Quiroga and J. Prieto, Liver cytoprotection by prostaglandins. Pharmac Ther. 58: 67 (1993)
H.S. Xu, L.K. Rosenlof, T.L. Pruett, and R.S. Jones, Prostaglandin E1 increases survival with extended anhepatic phase during liver transplantation. Ann Surg. 220: 53 (1994).
K.M. Olthoff, E. Wasef, and P. Seu, et al., PGE1 reduces injury in hepatic allografts following preservation. J Surg Res. 50: 595 (1991).
K. Takahaski, N. Yamamoto, and H. Egawa, et al., Effect of prostaglandin E1 on preservation of canine liver grafts preserved with UW solution. Transpl Int. 6: 245 (1993).
K.D. Chavin, L. Uber, P. Baliga, P. Rajagopalan, and J. Cofer, The effects of prostaglandin E1 on hepatic allograft vascular inflow: a prospective randomized double-blind study. Am Surg: 62: 184 (1996).
P. D. Greig, G. M. Woolf, and S. B. Sinclair, et al., Treatment of primary liver graft nonfunction with prostaglandin E1 Transplantation. 18: 447 (1989).
G. Himmelreich, K. Hundt, P. Neuhaus, W. O. Bechstein, P. Roissant, and H. Reiss, Influence of prostaglandin E1 infusion on hemostasis in orthotopic liver transplantation. Semin Thromb Hemos. 19: 273 (1993).
G. Himmelreich, K. Hundt, P. Neuhaus, W. O. Bechstein, R. Roissant, and H. Reiss, Evidence that intraoperative prostaglandin E1 infusion reduces impaired platelet aggregation after reperfusion in orthotopic liver transplantation. Transplantation. 55: 819(1993).
M. Moran, M. F. Mozes, and M. S. Maddux, et al., Prevention of acute graft rejection by the prostaglandin E1 analog misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. New Engl J Med. 322: 1183 (1990).
K. S. Henley, M. Lucey, and D. P. Normolle, et al., A double-blind randomized placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology. 21: 366(1993).
A. S. Klein, J. B. Cofer, and T. L. Pruett, et al., Prostaglandin E1 administration following orthotopic liver transplantation A randomized prospective multicenter trial Gastroenterology. 111: 710 (1996).
M. Asbert, A. Gines, and P. Gines, et al., Circulating levels of endothelin in cirrhosis Gastroenterology. 104: 1485 (1993).
A. O. Aktan, O. Buyukgebiz, and C. Yegen, et al., Does PGE2 act as a mediator for endothelin release? Prostaglandins Leukot Essent Fatty Acids. 50: 37 (1994).
D. G. Smith, K. S. Henley, C. S. Rernmert, S. L. Haas, D. A. Campbell, and I. D. McLaren, A cost analysis of alprostadil in liver transplantation. Pharmacoeconomics. 9: 517 (1996).
D. F. Schafer, and M. F. Sorrel, Prostaglandins in liver transplantation: a promise unfulfilled (editorial). Gastroenterology. 111: 819 (1996).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Merion, R.M. (1997). Prostaglandins in Liver Transplantation. In: Sinzinger, H., Samuelsson, B., Vane, J.R., Paoletti, R., Ramwell, P., Wong, P.YK. (eds) Recent Advances in Prostaglandin, Thromboxane, and Leukotriene Research. Advances in Experimental Medicine and Biology, vol 433. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-1810-9_3
Download citation
DOI: https://doi.org/10.1007/978-1-4899-1810-9_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4899-1812-3
Online ISBN: 978-1-4899-1810-9
eBook Packages: Springer Book Archive